[HTML][HTML] Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - International journal of antimicrobial agents, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
[PDF][PDF] Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives
Recently, the novel coronavirus disease 2019 (COVID-19), has attracted the attention of
scientists where it has a high mortality rate among older adults and individuals suffering from …
scientists where it has a high mortality rate among older adults and individuals suffering from …
COVID-19 and the kidney: from epidemiology to clinical practice
I Gagliardi, G Patella, A Michael, R Serra… - Journal of clinical …, 2020 - mdpi.com
The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …
[HTML][HTML] Immunomodulation for severe COVID-19 pneumonia: the state of the art
Y Zhang, Y Chen, Z Meng - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 has become a worldwide pandemic caused by the novel coronavirus named
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
D Darif, I Hammi, A Kihel, IEI Saik, F Guessous… - Microbial …, 2021 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …
Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies
ZA Abassi, K Skorecki, SN Heyman… - … of Physiology-Lung …, 2020 - journals.physiology.org
TO THE EDITOR: Coronavirus 2019 (also known as SARS-CoV-2, severe acute respiratory
syndrome coronavirus 2) binds to angiotensin-converting enzyme 2 receptors (ACE2) in …
syndrome coronavirus 2) binds to angiotensin-converting enzyme 2 receptors (ACE2) in …
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
A Copaescu, O Smibert, A Gibson, EJ Phillips… - Journal of Allergy and …, 2020 - Elsevier
The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …
[HTML][HTML] Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome
P Du, J Geng, F Wang, X Chen, Z Huang… - International journal of …, 2021 - ncbi.nlm.nih.gov
Cytokine release syndrome (CRS) may be the key factor in the pathology of severe
coronavirus disease 2019 (COVID-19). As a major driver in triggering CRS in patients with …
coronavirus disease 2019 (COVID-19). As a major driver in triggering CRS in patients with …
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
E Ahmadian, SM Hosseiniyan Khatibi… - Reviews in medical …, 2021 - Wiley Online Library
The novel coronavirus (SARS‐CoV‐2) has turned into a life‐threatening pandemic disease
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …